Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Caroline Fox, M.D.

Co-Author

This page shows the publications co-authored by Caroline Fox and James Meigs.
Connection Strength

7.200
  1. Genome-wide linkage analysis to urinary microalbuminuria in a community-based sample: the Framingham Heart Study. Kidney Int. 2005 Jan; 67(1):70-4.
    View in: PubMed
    Score: 0.301
  2. Incident Type 2 Diabetes Risk is Influenced by Obesity and Diabetes in Social Contacts: a Social Network Analysis. J Gen Intern Med. 2016 10; 31(10):1127-33.
    View in: PubMed
    Score: 0.165
  3. Metabolic factors and genetic risk mediate familial type 2 diabetes risk in the Framingham Heart Study. Diabetologia. 2015 May; 58(5):988-96.
    View in: PubMed
    Score: 0.151
  4. Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering. Metab Syndr Relat Disord. 2014 Sep; 12(7):372-80.
    View in: PubMed
    Score: 0.146
  5. The association of a single-nucleotide polymorphism in CUBN and the risk of albuminuria and cardiovascular disease. Nephrol Dial Transplant. 2014 Feb; 29(2):342-7.
    View in: PubMed
    Score: 0.138
  6. Analysis of a urinary biomarker panel for incident kidney disease and clinical outcomes. J Am Soc Nephrol. 2013 Nov; 24(11):1880-8.
    View in: PubMed
    Score: 0.137
  7. Lack of interaction of beta-cell-function-associated variants with hypertension on change in fasting glucose and diabetes risk: the Framingham Offspring Study. J Hypertens. 2013 May; 31(5):1001-9.
    View in: PubMed
    Score: 0.134
  8. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA. 2013 Mar 13; 309(10):1014-21.
    View in: PubMed
    Score: 0.133
  9. Neck circumference and the development of cardiovascular disease risk factors in the Framingham Heart Study. Diabetes Care. 2013 Jan; 36(1):e3.
    View in: PubMed
    Score: 0.131
  10. Periaortic adipose tissue and aortic dimensions in the Framingham Heart Study. J Am Heart Assoc. 2012 Dec; 1(6):e000885.
    View in: PubMed
    Score: 0.131
  11. A risk score for chronic kidney disease in the general population. Am J Med. 2012 Mar; 125(3):270-7.
    View in: PubMed
    Score: 0.124
  12. Variants at the endocannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart disease. Obesity (Silver Spring). 2011 Oct; 19(10):2031-7.
    View in: PubMed
    Score: 0.117
  13. Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study. Diabetologia. 2011 May; 54(5):1019-24.
    View in: PubMed
    Score: 0.115
  14. Type 2 diabetes risk in persons with dysglycemia: the Framingham Offspring Study. Diabetes Res Clin Pract. 2011 Apr; 92(1):124-7.
    View in: PubMed
    Score: 0.114
  15. Predictors of incident albuminuria in the Framingham Offspring cohort. Am J Kidney Dis. 2010 Nov; 56(5):852-60.
    View in: PubMed
    Score: 0.113
  16. A multi-marker approach to predict incident CKD and microalbuminuria. J Am Soc Nephrol. 2010 Dec; 21(12):2143-9.
    View in: PubMed
    Score: 0.113
  17. Common variants at 10 genomic loci influence hemoglobin A1(C) levels via glycemic and nonglycemic pathways. Diabetes. 2010 Dec; 59(12):3229-39.
    View in: PubMed
    Score: 0.112
  18. Inflammation, kidney function and albuminuria in the Framingham Offspring cohort. Nephrol Dial Transplant. 2011 Mar; 26(3):920-6.
    View in: PubMed
    Score: 0.111
  19. Periaortic fat deposition is associated with peripheral arterial disease: the Framingham heart study. Circ Cardiovasc Imaging. 2010 Sep; 3(5):515-9.
    View in: PubMed
    Score: 0.111
  20. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology. 2010 Jun; 51(6):1979-87.
    View in: PubMed
    Score: 0.110
  21. Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab. 2010 Aug; 95(8):3701-10.
    View in: PubMed
    Score: 0.109
  22. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring). 2010 Nov; 18(11):2191-8.
    View in: PubMed
    Score: 0.108
  23. The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans. Metabolism. 2010 Apr; 59(4):540-6.
    View in: PubMed
    Score: 0.105
  24. Arterial stiffness in mild-to-moderate CKD. J Am Soc Nephrol. 2009 Sep; 20(9):2044-53.
    View in: PubMed
    Score: 0.103
  25. Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the Framingham Heart Study. Diabetes Care. 2009 May; 32(5):903-8.
    View in: PubMed
    Score: 0.100
  26. Variants in the CNR1 and the FAAH genes and adiposity traits in the community. Obesity (Silver Spring). 2009 Apr; 17(4):755-60.
    View in: PubMed
    Score: 0.100
  27. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008 Nov 20; 359(21):2208-19.
    View in: PubMed
    Score: 0.099
  28. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes. 2008 Dec; 57(12):3353-9.
    View in: PubMed
    Score: 0.097
  29. Relations of measures of endothelial function and kidney disease: the Framingham Heart Study. Am J Kidney Dis. 2008 Nov; 52(5):859-67.
    View in: PubMed
    Score: 0.096
  30. Indexes of kidney function and coronary artery and abdominal aortic calcium (from the Framingham Offspring Study). Am J Cardiol. 2008 Aug 15; 102(4):440-3.
    View in: PubMed
    Score: 0.095
  31. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab. 2008 Aug; 93(8):3165-72.
    View in: PubMed
    Score: 0.095
  32. Burden and rates of treatment and control of cardiovascular disease risk factors in obesity: the Framingham Heart Study. Diabetes Care. 2008 Jul; 31(7):1367-72.
    View in: PubMed
    Score: 0.094
  33. Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease. Circulation. 2008 Feb 26; 117(8):1003-9.
    View in: PubMed
    Score: 0.093
  34. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol. 2008 Jan 22; 51(3):264-70.
    View in: PubMed
    Score: 0.093
  35. A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study. BMC Med Genet. 2007 Sep 19; 8 Suppl 1:S10.
    View in: PubMed
    Score: 0.091
  36. Genome-wide association with diabetes-related traits in the Framingham Heart Study. BMC Med Genet. 2007 Sep 19; 8 Suppl 1:S16.
    View in: PubMed
    Score: 0.091
  37. A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: replication and integration with other genome-wide datasets. Diabetes. 2007 Dec; 56(12):3063-74.
    View in: PubMed
    Score: 0.091
  38. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation. 2007 Sep 11; 116(11):1234-41.
    View in: PubMed
    Score: 0.090
  39. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Arch Intern Med. 2007 Jul 09; 167(13):1386-92.
    View in: PubMed
    Score: 0.090
  40. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care. 2007 Oct; 30(10):2529-35.
    View in: PubMed
    Score: 0.089
  41. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007 Jul 03; 116(1):39-48.
    View in: PubMed
    Score: 0.089
  42. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation. 2007 Mar 27; 115(12):1544-50.
    View in: PubMed
    Score: 0.088
  43. The type 2 deiodinase (DIO2) A/G polymorphism is not associated with glycemic traits: the Framingham Heart Study. Thyroid. 2007 Mar; 17(3):199-202.
    View in: PubMed
    Score: 0.087
  44. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care. 2007 May; 30(5):1219-25.
    View in: PubMed
    Score: 0.087
  45. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med. 2006 Sep 25; 166(17):1884-91.
    View in: PubMed
    Score: 0.085
  46. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation. 2006 Jun 27; 113(25):2914-8.
    View in: PubMed
    Score: 0.083
  47. Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample. Kidney Int. 2006 Jun; 69(11):2064-9.
    View in: PubMed
    Score: 0.083
  48. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006 Aug; 91(8):2906-12.
    View in: PubMed
    Score: 0.083
  49. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample. Obesity (Silver Spring). 2006 May; 14(5):753-8.
    View in: PubMed
    Score: 0.083
  50. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes. 2006 Feb; 55(2):530-7.
    View in: PubMed
    Score: 0.081
  51. Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care. 2005 Oct; 28(10):2436-40.
    View in: PubMed
    Score: 0.079
  52. Trends in cardiovascular complications of diabetes. JAMA. 2004 Nov 24; 292(20):2495-9.
    View in: PubMed
    Score: 0.075
  53. Ambient air pollution, adipokines, and glucose homeostasis: The Framingham Heart Study. Environ Int. 2018 02; 111:14-22.
    View in: PubMed
    Score: 0.046
  54. An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans. Diabetes. 2017 11; 66(11):2888-2902.
    View in: PubMed
    Score: 0.044
  55. Sugar-Sweetened Beverage but Not Diet Soda Consumption Is Positively Associated with Progression of Insulin Resistance and Prediabetes. J Nutr. 2016 Dec; 146(12):2544-2550.
    View in: PubMed
    Score: 0.043
  56. Peripheral Blood Transcriptomic Signatures of Fasting Glucose and Insulin Concentrations. Diabetes. 2016 Dec; 65(12):3794-3804.
    View in: PubMed
    Score: 0.042
  57. Rare variant associations with waist-to-hip ratio in European-American and African-American women from the NHLBI-Exome Sequencing Project. Eur J Hum Genet. 2016 08; 24(8):1181-7.
    View in: PubMed
    Score: 0.040
  58. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet. 2015 Dec; 47(12):1415-25.
    View in: PubMed
    Score: 0.040
  59. Directional dominance on stature and cognition in diverse human populations. Nature. 2015 Jul 23; 523(7561):459-462.
    View in: PubMed
    Score: 0.039
  60. Integromic analysis of genetic variation and gene expression identifies networks for cardiovascular disease phenotypes. Circulation. 2015 Feb 10; 131(6):536-49.
    View in: PubMed
    Score: 0.038
  61. Sugar-sweetened beverages and prevalence of the metabolically abnormal phenotype in the Framingham Heart Study. Obesity (Silver Spring). 2014 May; 22(5):E157-63.
    View in: PubMed
    Score: 0.036
  62. Pericardial fat is associated with atrial conduction: the Framingham Heart Study. J Am Heart Assoc. 2014 Mar 04; 3(2):e000477.
    View in: PubMed
    Score: 0.036
  63. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet. 2014 Mar; 46(3):234-44.
    View in: PubMed
    Score: 0.035
  64. Predicting stroke through genetic risk functions: the CHARGE Risk Score Project. Stroke. 2014 Feb; 45(2):403-12.
    View in: PubMed
    Score: 0.035
  65. Longitudinal association between dairy consumption and changes of body weight and waist circumference: the Framingham Heart Study. Int J Obes (Lond). 2014 Feb; 38(2):299-305.
    View in: PubMed
    Score: 0.034
  66. Risk of type 2 diabetes and cumulative excess weight exposure in the Framingham Offspring Study. J Diabetes Complications. 2013 May-Jun; 27(3):214-8.
    View in: PubMed
    Score: 0.033
  67. Yogurt consumption is associated with better diet quality and metabolic profile in American men and women. Nutr Res. 2013 Jan; 33(1):18-26.
    View in: PubMed
    Score: 0.033
  68. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012 Sep; 44(9):981-90.
    View in: PubMed
    Score: 0.032
  69. Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study. Diabetol Metab Syndr. 2012 Jun 20; 4(1):28.
    View in: PubMed
    Score: 0.032
  70. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet. 2012 May 13; 44(6):659-69.
    View in: PubMed
    Score: 0.031
  71. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012; 8(3):e1002607.
    View in: PubMed
    Score: 0.031
  72. No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels. Diabetes. 2012 May; 61(5):1291-6.
    View in: PubMed
    Score: 0.031
  73. Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet. 2012 Mar 09; 90(3):410-25.
    View in: PubMed
    Score: 0.031
  74. A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One. 2012; 7(1):e29202.
    View in: PubMed
    Score: 0.031
  75. Common genetic variants differentially influence the transition from clinically defined states of fasting glucose metabolism. Diabetologia. 2012 Feb; 55(2):331-9.
    View in: PubMed
    Score: 0.030
  76. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes. 2011 Oct; 60(10):2624-34.
    View in: PubMed
    Score: 0.030
  77. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes. 2011 Sep; 60(9):2407-16.
    View in: PubMed
    Score: 0.030
  78. Association between parental history of diabetes and type 2 diabetes genetic risk scores in the PPP-Botnia and Framingham Offspring Studies. Diabetes Res Clin Pract. 2011 Aug; 93(2):e76-e79.
    View in: PubMed
    Score: 0.029
  79. CUBN is a gene locus for albuminuria. J Am Soc Nephrol. 2011 Mar; 22(3):555-70.
    View in: PubMed
    Score: 0.029
  80. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011 Feb 01; 123(4):e18-e209.
    View in: PubMed
    Score: 0.028
  81. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care. 2011 Jan; 34(1):121-5.
    View in: PubMed
    Score: 0.028
  82. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010 Jul; 42(7):579-89.
    View in: PubMed
    Score: 0.028
  83. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet. 2010 Jul 01; 19(13):2706-15.
    View in: PubMed
    Score: 0.027
  84. Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes. 2010 May; 59(5):1266-75.
    View in: PubMed
    Score: 0.027
  85. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet. 2010 Feb; 42(2):142-8.
    View in: PubMed
    Score: 0.027
  86. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010 Feb; 42(2):105-16.
    View in: PubMed
    Score: 0.027
  87. Pericardial fat volume correlates with inflammatory markers: the Framingham Heart Study. Obesity (Silver Spring). 2010 May; 18(5):1039-45.
    View in: PubMed
    Score: 0.026
  88. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study. Diabetologia. 2009 Apr; 52(4):614-20.
    View in: PubMed
    Score: 0.025
  89. Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes. 2009 Mar; 58(3):750-6.
    View in: PubMed
    Score: 0.025
  90. Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009 Jan; 41(1):77-81.
    View in: PubMed
    Score: 0.025
  91. TCF7L2 variants associate with CKD progression and renal function in population-based cohorts. J Am Soc Nephrol. 2008 Oct; 19(10):1989-99.
    View in: PubMed
    Score: 0.024
  92. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care. 2008 Oct; 31(10):1991-6.
    View in: PubMed
    Score: 0.024
  93. Haplotype structure of the ENPP1 Gene and Nominal Association of the K121Q missense single nucleotide polymorphism with glycemic traits in the Framingham Heart Study. Diabetes. 2008 Jul; 57(7):1971-7.
    View in: PubMed
    Score: 0.024
  94. Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol. 2008 Jan 01; 101(1):82-8.
    View in: PubMed
    Score: 0.023
  95. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Circulation. 2007 Aug 28; 116(9):984-92.
    View in: PubMed
    Score: 0.023
  96. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation. 2007 Jul 31; 116(5):480-8.
    View in: PubMed
    Score: 0.022
  97. Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals. Circulation. 2007 Jul 24; 116(4):375-84.
    View in: PubMed
    Score: 0.022
  98. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med. 2007 May 28; 167(10):1068-74.
    View in: PubMed
    Score: 0.022
  99. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes. 2007 Jun; 56(6):1718-26.
    View in: PubMed
    Score: 0.022
  100. The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet. 2007; 8 Suppl 1:S1.
    View in: PubMed
    Score: 0.022
  101. BMI modifies associations of IL-6 genotypes with insulin resistance: the Framingham Study. Obesity (Silver Spring). 2006 Aug; 14(8):1454-61.
    View in: PubMed
    Score: 0.021
  102. Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure. Circulation. 2005 Sep 20; 112(12):1719-27.
    View in: PubMed
    Score: 0.020
  103. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005 Aug 16; 112(7):969-75.
    View in: PubMed
    Score: 0.020
  104. Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study. Am J Hypertens. 2005 May; 18(5 Pt 1):657-65.
    View in: PubMed
    Score: 0.019
  105. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation. 2005 Mar 22; 111(11):1370-6.
    View in: PubMed
    Score: 0.019
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.